FDA Action Affects Products Manufactured by Elite Pharmaceuticals, Inc.

10-03-2011 IEWY NewsComments (0)

Pharmaceutical

Northvale, New Jersey, : Elite Pharmaceuticals, Inc. (OTC:BB: ELTP) advises that the US Food and Drug Administration (FDA) announced that it intends to remove approximately 500 cough/cold and allergy related products from the US market. ...

Read more on IEWY News

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top